- Home
- MPTI vs CGTX Comparison
MPTI vs CGTX Comparison
Compare MPTI & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPTI
- CGTX
- Stock Information
- Founded
- MPTI 1965
- CGTX 2007
- Country
- MPTI United States
- CGTX United States
- Employees
- MPTI N/A
- CGTX N/A
- Industry
- MPTI
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- MPTI
- CGTX Health Care
- Exchange
- MPTI Nasdaq
- CGTX Nasdaq
- Market Cap
- MPTI 117.1M
- CGTX 79.3M
- IPO Year
- MPTI N/A
- CGTX 2021
- Fundamental
- Price
- MPTI $51.94
- CGTX $0.55
- Analyst Decision
- MPTI
- CGTX Buy
- Analyst Count
- MPTI 0
- CGTX 6
- Target Price
- MPTI N/A
- CGTX $8.00
- AVG Volume (30 Days)
- MPTI 33.0K
- CGTX 588.8K
- Earning Date
- MPTI 11-07-2024
- CGTX 11-08-2024
- Dividend Yield
- MPTI N/A
- CGTX N/A
- EPS Growth
- MPTI 87.47
- CGTX N/A
- EPS
- MPTI 1.76
- CGTX N/A
- Revenue
- MPTI $44,654,000.00
- CGTX N/A
- Revenue This Year
- MPTI $18.43
- CGTX N/A
- Revenue Next Year
- MPTI $8.16
- CGTX N/A
- P/E Ratio
- MPTI $30.37
- CGTX N/A
- Revenue Growth
- MPTI 22.02
- CGTX N/A
- 52 Week Low
- MPTI $21.04
- CGTX $0.34
- 52 Week High
- MPTI $54.00
- CGTX $2.95
- Technical
- Relative Strength Index (RSI)
- MPTI 70.52
- CGTX 54.28
- Support Level
- MPTI $48.47
- CGTX $0.50
- Resistance Level
- MPTI $54.00
- CGTX $0.64
- Average True Range (ATR)
- MPTI 2.91
- CGTX 0.07
- MACD
- MPTI -0.04
- CGTX 0.02
- Stochastic Oscillator
- MPTI 83.43
- CGTX 67.74
About MPTI M-tron Industries Inc.
M-Tron Industries Inc is a diversified holding company with subsidiaries engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The serving markets of the company are aerospace and defense, space, and avionics. The company offers products such as microwave and millimeter wave filters; cavity, crystal, ceramic, lumped element, and switched filters; crystal resonators, integrated microwave assemblies, and solid-state power amplifier products.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.